English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPeople suffering from long COVID symptoms show different immune and hormonal responses to the virus that causes COVID-19, according to a new study led by researchers at Yale School of Medicine. An estimated 7.5% of people infected with the SARS-CoV-2…
Tag: covid
Common symptoms of COVID-19 and often-overlooked symptoms
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. COVID-19 has been around for three years now. What are some of the recent common symptoms we are seeing? (SOT@…
ACP issues updated Rapid, Living Practice Points on treating COVID-19 patients in outpatient settings
In an updated rapid, living practice points, the American College of Physicians (ACP) summarizes the latest evidence on the use of pharmacologic and biologic treatments of COVID-19 in the outpatient setting, specifically addressing the dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. The paper is published in Annals of Internal Medicine
Promising Gene-Based Approaches to Repair Lethal Lung Injury in the Elderly from COVID-19, Pneumonia, Flu, Sepsis
Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis.
Getting vaccines for flu, RSV, pneumonia and COVID.
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. With flu season approaching, who should get a flu shot and when? (SOT@ :14, TRT :24) RSV cases…
Remoteness didn’t protect Amazonian Tsimané from COVID-19
Voluntary collective isolation alone was ineffective to mitigate the spread of COVID-19 into small-scale, remote Indigenous communities of the Tsimané in the Bolivian Amazon.
Dr. Carol Nwelue discusses how to keep your kids healthy when going back to school.
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. How can parents keep their kids healthy this back-to-school season? (SOT@ 0:14, TRT 0:34) Why do sicknesses spread easily when…
Dr. Marc Elieson discusses concerns about COVID-19 and kids going back to school
Marc Elieson, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. The CDC says COVID cases will continue to increase this summer and when school resumes this fall. What is behind…
EG.5 COVID Variant: Johns Hopkins Bloomberg School of Public Health expert available
Andrew Pekosz, professor and vice chair of the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, is available for media interviews to discuss the EG.5 COVID variant, which the Centers for Disease Control…
An adjuvanted intranasal vaccine for COVID-19 protects both young and old mice
A collaborative research effort led by the University of Michigan and the Icahn School of Medicine at Mount Sinai has resulted in a nasal vaccine adjuvant that stops COVID infection in both young and old mice.
Early-Stage Cancer Diagnoses Decreased Sharply in the U.S. During First Year of COVID-19 Pandemic; Underserved Greatly Affected
A new study from researchers at the American Cancer Society found monthly adult cancer diagnoses decreased by half in April 2020 during the COVID-19 pandemic in the United States. The largest decrease was for stage I cancers, resulting in a higher proportion of late-stage diagnoses.
Breaking Research Sheds Light on COVID, Flu, and RSV Co-infections
Today, at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, scientists will present new data about rates of co-infections with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) in the United States.
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.
Adding a single data point to COVID-19 reporting may more accurately convey the real-time burden of infection in health care settings
In a new ‘Medicine and Public Issues,’ authors from Tufts Medical Center, Veterans Affairs Boston Healthcare System, Harvard Medical School and the Massachusetts Department of Public Health advocate for the inclusion of both the total number of COVID-19 hospitalizations daily and the number of inpatients who received dexamethasone at any point during their hospital stay. The authors emphasize that the addition of this data element is an easy and much-needed update to COVID-19 surveillance efforts that may help to more accurately convey the real-time burden of a rapidly changing infection in health care settings. The article is published in Annals of Internal Medicine.
Novel Rutgers COVID Vaccine May Provide Long-Lasting Protection
Rutgers team that created the new COVID vaccine aims to partner with a pharmaceutical company to launch human trials.
Study Identifies Messages about Vaccinating Children Against COVID-19 That Resonate Best with Vaccine-Hesitant Parents
A study from Ann & Robert H. Lurie Children’s Hospital of Chicago found that parents with children who were not yet vaccinated against COVID-19 were most likely to vaccinate their child after reading the following hypothetical scenario.
Why Subvariants of the SARS-CoV-2 Virus Accelerated the Pandemic
UC San Diego researchers describe why SARS-CoV-2 subvariants spread more rapidly than the original virus strain, and how an early treatment might have made people more susceptible to future infections.
Harvard Medical School Media Immersion: Boston, June 8-9, 2023
Application deadline: March 31
Nanomaterial Boosts Potency of Coronavirus Disinfectants
Enhanced disinfectant is two-to-four times more effective in neutralizing pathogen threat
Johns Hopkins Nursing’s Silver Linings from Pew Research study ‘Parenting in America Today’
Raising children is, has been, and almost certainly will remain one of life’s great challenges. (Ask your parents.) Yet new data from the Pew Research Center show that 62 percent of parents across the board and the nation are finding it even more difficult than they ever imagined.
Can the Lingering Effects of a Mild Case of COVID-19 Change Your Brain?
People with long COVID who experience anxiety and depression months after a mild case of COVID-19 may have brain changes that affect the function and structure of the brain, according to a preliminary study released today, February 20, 2023, that will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.
Education levels impact on belief in scientific misinformation and mistrust of COVID-19 preventive measures
A new study has found that people with a university degree were less likely to believe in COVID-19 misinformation and more likely to trust preventive measures than those without a degree.
Children’s Hospital Los Angeles Study of Childhood COVID-19 Immunity Could Safeguard Babies Too Young for COVID-19 Vaccination
Pia Pannaraj, MD, MPH, an infectious disease specialist at Children’s Hospital Los Angeles, was awarded $4.2 million from the National Institutes of Health to study COVID-19 immunity in children.
Deer carry SARS-CoV-2 variants that are extinct in humans
Cornell University researchers have found white-tailed deer – the most abundant large mammal in North America – are harboring SARS-CoV-2 variants that were once widely circulated, but no longer found in humans.
COVID by the numbers at UCLA Health: A million tests; 300,000 vaccines; 55,000 patients
Three years ago this month, the first case of COVID was diagnosed in the United States. Here are the latest figures on the pandemic, collected by UCLA Health hospitals and clinics.
Wearable, Printable, Shapeable Sensors Detect Pathogens and Toxins in the Environment
Researchers at Tufts University have created a biopolymer sensor that can be printed on or embedded in wide range of materials, including gloves, masks, and everyday clothing. The sensor lights up when exposed to specific pathogens, toxins, proteins, or chemicals.
Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus’ Initial Mutation that Enabled Its Spread
Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.
Research sheds light on how countries responded to the COVID-19 pandemic
A new paper by a team at Los Alamos National Laboratory is giving researchers new insight into how countries respond to systemic shocks such as the COVID-19 pandemic.
Telehealth cuts health care’s carbon footprint and patient’s costs during pandemic
UC Davis Health researchers assessed the carbon footprint and potential savings in lives, costs and time of telehealth visits during the pandemic’s first two years. They found that video visits in five UC health systems resulted in substantial savings in patient costs and carbon emissions.
Data Analytics Could Prevent Testing Bottlenecks During Future Pandemics
Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic. These findings, published in the Data Science Issue of AACC’s The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
Podcast: From bedside to industry: Epilepsy career profile of Dr. Caroline Neuray
Dr. Alina Ivaniuk talks with Dr. Neuray about her career path from medical school to industry CEO. They discuss the power of peer mentoring, ways to improve medical education, and finding the courage to accept change.
‘Adaptive Leadership’ Led to Successful COVID-19 Response in Alaskan Capital
A research team that studied Juneau’s early response to the pandemic has identified a number of factors that helped the Alaskan capital mitigate COVID-19’s impact on residents.
Researchers Leverage Pathogen “Fingerprints” in Blood to Accelerate Infection Diagnosis
MEDIA ADVISORY UNDER EMBARGO UNTIL DECEMBER 21, 2022 in Cell Systems Corresponding Authors: Elena Zaslavsky, PhD, Associate Professor of Neurology, Icahn School of Medicine at Mount Sinai; Steven H. Kleinstein, PhD, Anthony Brady Professor of Pathology at Yale School of…
New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.
Saint Joseph’s University Expert Available to Discuss China’s COVID Restrictions and Ongoing Protests
Demonstrators in China continue to protest the country’s strict coronavirus measures. James Carter, PhD, dean of Saint Joseph’s College of Arts and Sciences, is a leading and celebrated scholar on China’s modern history, having published three books on related topics…
Severe COVID-19 Linked with Molecular Signatures of Brain Aging, Researchers Find
In a series of experiments, scientists found that gene usage in the brains of patients with COVID-19 is similar to those observed in aging brains.
Rutgers Infectious Disease Expert Can Discuss Staying Healthy at Holiday Gatherings
Diana Finkel, an assistant professor of medicine and director of the Infectious Disease Fellowship Program at Rutgers New Jersey Medical School, is available for interviews on how people can minimize their chances of getting sick at holiday gatherings (without eating…
Registration Opens for Premier Critical Care Nursing Conference
Registration is now open for AACN’s National Teaching Institute & Critical Care Exposition (NTI), to be held in Philadelphia, May 22-24, 2023. The NTI experience will address nearly 50 clinical and professional development topics and include the largest and most comprehensive trade show expressly for progressive and critical care nurses.
Study Explores Sex Differences in the Effects of SARS-CoV-2 in Young Adults
Suggests a more proactive, innate immune response among females
The future of the labor market and the economy: A conversation with Dan Graff
Daniel Graff is director of the University of Notre Dame’s Higgins Labor Program. Here, he explores the resurgence of unionization efforts, the future of the U.S. labor market and its impact on the economy.
‘Prime and Spike’ nasal vaccine strategy helps combat COVID
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science.
Potential therapy derived from a banana protein works against SARS-CoV-2
A paper in Cell Reports Medicine details the efficacy of H84T-BanLec against all known human-infecting coronaviruses, including MERS, the original SARS, and SARS-CoV2, including the omicron variant.
Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine
The annual influenza (flu) season — which typically lasts from October to April in the United States — is upon us. Johns Hopkins Medicine experts will be available throughout the 2022–23 season for interviews about this year’s flu virus and flu vaccine, as well as other respiratory illnesses, such as COVID-19 and monkeypox.
Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine 50 mg twice daily for 10 days for the treatment of mild-to-moderate COVID-19 symptoms.
Penn State scientists one step closer to adaptation-proof COVID-19 vaccine
A vaccine that could protect against new variants of SARS-CoV-2 and also potentially protect against other coronaviruses is one step closer to reality thanks to College of Medicine researchers.
University Hospitals Team Receives Grant to Study Long-term Consequences and Outcomes of COVID-19 and other Viruses
A team at University Hospitals in Cleveland aims to unearth potential immunologic mechanisms and understanding of COVID-19 upon long-term consequences and outcomes thanks to a grant from the American Lung Association.
Before test results, signs of COVID-19 are in water systems
A new study from the Lab of Fangqiong Ling at the McKelvey School of Engineering will help facilitate the exchange of data and results between engineers and medical researchers, leading to a more robust understanding of the relationships between viruses moving through the engineered world and diseases spreading through populations.
More than 16,000 Cancer Deaths Due to Complications from COVID-19 in 2020 in U.S., New Study Says
From March through December 2020, more than 16,000 cancer deaths were due to complications of COVID-19 in the United States, according to a new study led by researchers at the American Cancer Society.
Vaccinating women infected with COVID during pregnancy prior to delivery provides antibodies to newborns
FINDINGS Women with COVID in pregnancy who are subsequently vaccinated after recovery, but prior to delivery, are more likely to pass antibodies on to the child than similarly infected but unvaccinated mothers are. Researchers who studied a mix of vaccinated and unvaccinated mothers found that 78% of their infants tested at birth had antibodies.
COVID-19 associated with increase in new diagnoses of type 1 diabetes in youth, by as much as 72%
Children who were infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study that analyzed electronic health records of more than 1 million patients ages 18 and younger.